๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Secondary flows and the pool-riffle unit: A case study of the processes of meander development

โœ Scribed by Alan Thompson


Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
784 KB
Volume
11
Category
Article
ISSN
0360-1269

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A dual-level analysis of the capability
โœ Shan Pan; Gary Pan; Ming H. Hsieh ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 145 KB ๐Ÿ‘ 2 views

## Abstract The resourceโ€based view suggests that organizations achieve and maintain competitive advantage through effective deployment of firmโ€specific resources and capabilities. Because of volatile market conditions, researchers now focus on the development of dynamic capabilities that allow fir

Sustainable Development in Practice (Cas
โœ Azapagic, Adisa; Perdan, Slobodan; Clift, Roland ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley & Sons, Ltd ๐ŸŒ English โš– 307 KB ๐Ÿ‘ 2 views

this Ground-breaking Text Looks At The Ways Of Integrating Sustainability Aspects Into Science And Engineering. In Providing An All-round Sustainability Education, Itย teaches Students Within Engineering And Environmental Science Theย implications Of Their Decisions On The Environment. Taking A Life

Chlamydia trachomatis and invasive cervi
โœ Jennifer S. Smith; Cristina Bosetti; Nubia Muรฑoz; Rolando Herrero; F. Xavier Bos ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 124 KB

## Abstract To determine whether __Chlamydia trachomatis__ infection is consistently associated with an increased risk of invasive cervical carcinoma (ICC) after accounting for the strong effect of human papillomavirus (HPV) infection, a caseโ€control study of 1,238 cases of ICC and 1,100 control wo

Monitoring of intracellular ribonucleoti
โœ Stefanos I. Grammatikos; Kai Tobien; Wolfgang Noรฉ; Rolf G. Werner ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 242 KB

Efficient cell culture process development for the industrial production of recombinant therapeutics is characterized by constraints which pertain to issues such as costs, competitiveness and the meeting of project timelines. These constraints require tools which can help the developer learn as much